Search Tag: coronavirus vaccine

Executive Health Management

2020 18 Nov

Pfizer has completed the Phase 3 of its COVID-19 vaccine trial and is ready to seek authorisation for emergency use in the U.S. The vaccine is reported to be 95% effective. Two other vaccine candidates, those of Moderna and the Russian Gamaleya Research Institute, demonstrated 94.5% and 92% efficacy, respectively, but the trials are still...Read more

Executive Health Management

2020 30 Oct

Availability of an effective vaccine is viewed as crucial in the fight against COVID-19, but researchers warn against ‘vaccine nationalism’. The latest vaccine development updates are aggregated in a new online tracker.   You might also like: Grand Plans for Potential COVID-19 Vaccine Production   Cost of ‘Vaccine Nationalism’...Read more

Executive Health Management

2020 08 Jun

UK-based drugmaker AstraZeneca expands its plans with regard to the COVID-19 vaccine, doubling its manufacturing capacity to 2 billion doses and securing deals with a number of partners.   You might also like: EU Supports Clinical Trials During COVID-19   The vaccine, AZD1222 (previously known as ChAdOx1 nCoV-19), was developed...Read more